# Review Record — Week 1
## AI Reviews of Agent Design

Three AI reviews to be completed after preprint draft:

### Review 1 — Practitioner Review
**Prompt:** You are a biomedical engineer who has built wearable ECG
devices commercially. Review this agent design for real-world feasibility.

**Response:**
Signal quality: Single/few-lead wearable ECG has high artifact rates
(motion, poor electrode contact, sweat). ST-segment measurement is
notoriously unreliable outside clinical 12-lead settings.

The 2,500:1 ratio is a trap: It mathematically justifies escalating
almost everything, which sounds "safe" but isn't free — alert fatigue
leads users/clinicians to ignore escalations, and false-positive
escalations have real downstream costs not captured in the $200 figure.

35%/0.02% thresholds are fake precision: No validated model gives
calibrated probability at those resolutions from consumer ECG features.

**Suggested improvements:**
1. Add a 4th state: "signal insufficient — retake/reposition"
2. Validate against real wearable data, not clinical-grade assumptions
3. Widen HOLD zone; escalation threshold should account for
   repeat-measurement confirmation
4. Track false-escalation rate over time — cost model needs a
   fatigue/trust decay term

**What changed in agent design:**
The practitioner independently confirmed alert fatigue as a real
constraint. The suggestion of a 4th hidden state ("signal insufficient")
validates the two-stage framing raised earlier. Added as future direction.

---

### Review 2 — Probability Review
**Prompt:** You are a statistician reviewing a decision-theoretic agent
design. Evaluate the cost reasoning and threshold derivations.

**Response:**
Math checks out, but the model is too thin to trust.

Reasoning validity: The threshold logic is internally consistent
arithmetic — comparing p×C(miss) vs (1-p)×C(false-positive) is a
legitimate decision-theoretic setup. The three-action structure
(dismiss/HOLD/escalate) is more sophisticated than a simple
two-threshold model, but HOLD's own cost needs explicit justification.

**Implicit assumptions flagged:**
- $500,000 and $200 are fixed point estimates with no distribution
- Costs are purely monetary — no disutility for death or disability
- Probability estimate p is assumed well-calibrated and error-free
- Linear utility in dollars (ignores risk aversion)
- Costs are static over time and context

**What's missing:**
- Sensitivity/specificity of the underlying risk model
- Confidence intervals on p — point estimates near thresholds are fragile
- Downstream costs of false negatives beyond $500K (legal, systemic trust)
- Opportunity cost of escalation (resource scarcity)

**What changed in agent design:**
Confirmed three-action structure is theoretically justified. Added
explicit cost of HOLD action to future work: HOLD is not free —
delay cost must be bounded by maximum HOLD time definition.

---

### Review 3 — Conference Reviewer
**Prompt:** You are a peer reviewer for a medical AI conference.
Review this preprint for clarity, novelty, and soundness.

**Response:**
Novelty: Moderate, not high. Bayesian belief updating with
cost-sensitive thresholds is well-established (sequential decision
theory, POMDPs applied to clinical triage). Novelty rests on the
wearable ECG + ST-segment + hidden-state formulation specifically,
which needs sharper differentiation from prior work.

**Soundness concerns:**
- 2,500:1 ratio treated as ground truth — no sensitivity analysis
- "High accuracy but misses critical cases" is vague — needs actual
  metrics for comparison baselines
- No mention of validation data or clinical evaluation

**To be publishable:**
1. Report performance against baselines (AUC, sensitivity at fixed
   specificity, calibration)
2. Justify cost parameters with literature or expert elicitation
3. Clinical validation on real ECG datasets (PTB-XL)
4. Clarify novelty relative to existing POMDP/triage literature

**What changed in agent design:**
PTB-XL added as secondary dataset target alongside MIT-BIH.
Sensitivity analysis on cost parameters identified as key gap
for Week 2 extension.

---

## Summary of What Reviews Changed

| Review | Key Finding | Impact on Agent |
|---|---|---|
| Practitioner | Alert fatigue not modeled | Add fatigue/trust decay as future work |
| Practitioner | 4th hidden state needed | "Signal insufficient" as future extension |
| Statistician | HOLD cost not justified | Maximum HOLD time bounds delay cost |
| Statistician | Point estimates are fragile | Sensitivity analysis needed |
| Conference | Novelty needs sharpening | Differentiate from POMDP literature |
| Conference | No baseline comparison | Future: compare vs dumb threshold alarm |

---
*Reviews completed — Week 1 Sprint*
